Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 3 4Phase NA 3Phase 2 3Phase 4 2

Status

Completed 4Unknown 2Recruiting 2Withdrawn 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Dermatologic 1Classical hematology 1

Conditions

Pain 1Neoplasms 1Lung Neoplasms 1Keratosis, Actinic 1Anemia 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × Solutions × Clear all
NCT00711958 2017-09-05

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

Sandoz

Phase 3 Completed
114 enrolled 10 charts
Classical hematology

Anemia

NCT01836328 2016-03-16

RATIOMTD

L'Hospitalet de Llobregat

Phase 3 Completed
44 enrolled

Neoplasms, Pain

NCT02137785 2015-09-16

Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities

DUSA Pharmaceuticals, Inc.

Phase 3 Completed
269 enrolled 61 charts
Dermatologic

Keratosis, Actinic

NCT00210080 2015-09-04

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

Merck Sharp & Dohme LLC

Phase 3 Completed
700 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡